Total Clarity Wealth Management’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$320K Buy
+7,503
New +$407K 0.06% 291
2022
Q3
– Sell
-249
Closed -$9K – 310
2022
Q2
$9K Buy
+249
New +$10.1K ﹤0.01% 684
2022
Q1
– Sell
-167
Closed -$7K – 296
2021
Q4
$7K Hold
167
– – ﹤0.01% 747
2021
Q3
$7K Buy
+167
New +$7.39K ﹤0.01% 746
2021
Q2
– Sell
-167
Closed -$6K – 254
2021
Q1
$6K Buy
+167
New +$6.32K ﹤0.01% 645
2020
Q1
– Sell
-167
Closed -$8K – 149
2019
Q4
$8K Buy
+167
New +$6.99K 0.01% 520

Other funds holding BSX

Total Clarity Wealth Management's BSX Position: Q2 2026 in Review

Total Clarity Wealth Management opened a new position in Boston Scientific (BSX) in Q2 2026: 7,503 shares worth $320K. The stake represents 0.06% of the portfolio and ranks #291 among its holdings. This is a return to the name: Total Clarity Wealth Management previously reported a position in BSX as recently as Q2 2022.

Total Clarity Wealth Management first reported a position in BSX in Q4 2019 and has held it in 6 quarters since. 1,487 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Total Clarity Wealth Management held 7,503 shares of Boston Scientific worth $320K as of Q2 2026.
  • Boston Scientific was a new Total Clarity Wealth Management position in Q2 2026.
  • Boston Scientific made up 0.06% of Total Clarity Wealth Management's portfolio in Q2 2026, its #291 holding.
  • Total Clarity Wealth Management first reported a position in Boston Scientific in Q4 2019 and has held it in 6 quarters since.
  • 1,487 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Total Clarity Wealth Management's 13F filing for Q2 2026, filed 23 Jul 2026.